During the past decade, KardioPrax Remscheid conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "KardioPrax Remscheid" #1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator, "ClinStat GmbH" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "KardioPrax Remscheid" are "Chronic Kidney Disease (CKD)" (1 trials), "Iron Deficiency" (1 trials), "Non-valvular Atrial Fibrillation (NVAF)" (1 trials) and "Systolic Heart Failure" (1 trials). Many other conditions were trialed in "KardioPrax Remscheid" in a lesser frequency.

Most popular intervention types in "KardioPrax Remscheid" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Iron" (1 trials) and "Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "KardioPrax Remscheid" are 2 trials for "All" genders.

Currently, there are NaN active trials in "KardioPrax Remscheid". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in KardioPrax Remscheid, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in KardioPrax Remscheid, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".